BioHarvest Sciences Inc. Common Stock (BHST) Earnings History
Net Loss13 years of earnings data (2013–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
BioHarvest Sciences Inc. Common Stock (BHST) Earnings Overview
As of June 28, 2026, BioHarvest Sciences Inc. Common Stock (BHST) reported trailing twelve-month net income of -$11M, reflecting +25.0% year-over-year growth. The company earned $-0.50 per diluted share over the past four quarters, with a net profit margin of -32.3%.
Looking at the long-term picture, BHST's historical earnings data spans multiple years. The company achieved its highest annual net income of $0 in fiscal 2013.
BioHarvest Sciences Inc. Common Stock is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NXRT (-$32M net income, -12.7% margin), GFAI (-$13M net income, -18.9% margin), SIGA ($20M net income, 24.6% margin), BHST has room to improve margins relative to the peer group. Compare BHST vs NXRT →
BHST Earnings vs Peers
Earnings metrics vs comparable public companies
BHST Historical Earnings Data (2013–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$11M | +13.8% | -$6M | $-0.60 | -32.3% | -16.2% |
| 2024 | -$13M | -2.8% | -$7M | $-0.80 | -51.3% | -27.7% |
| 2023 | -$13M | -11.8% | -$10M | $-0.93 | -99.1% | -78.6% |
| 2022 | -$11M | -14.3% | -$11M | $-0.70 | -204.4% | -193.0% |
| 2021 | -$10M | -49.3% | -$8M | $-0.70 | -467.5% | -403.9% |
| 2020 | -$7M | -24.0% | -$6M | $-0.70 | -1662.6% | -1557.1% |
| 2019 | -$5M | - | -$2M | $-1.75 | -2435.8% | -1059.6% |
| 2018 | $0 | - | -$4M | $-2.34 | - | - |
| 2017 | $0 | - | $0 | $-0.21 | - | - |
| 2016 | $0 | - | $-93,081 | $-0.19 | - | - |
| 2015 | $0 | - | $-127,743 | $-0.44 | - | - |
| 2014 | $0 | - | $0 | $-0.72 | - | - |
| 2013 | $0 | - | $0 | $-1.17 | - | - |
Download Data
Export BHST earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
13+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BHST — Frequently Asked Questions
Quick answers to the most common questions about buying BHST stock.
What is BHST earnings per share (EPS)?
BHST trailing twelve-month (TTM) diluted EPS is $-0.50, reflecting +25.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2013 to 2025 is available in the table on this page.
What is BioHarvest Sciences Inc. Common Stock's net income?
BioHarvest Sciences Inc. Common Stock (BHST) trailing twelve-month net income is $-11M as of 2025. Earnings grew +25.0% year-over-year.
Is BHST profitable?
BHST is not currently profitable on a TTM basis, reporting a net loss of $-11M. Net margin is -32.3%. Investors should monitor for a return to profitability.
What is BHST's earnings growth rate?
BHST compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2013 to 2025.
What are BHST's profit margins?
BioHarvest Sciences Inc. Common Stock net profit margin is -32.3%, operating margin is -16.2%, and gross margin is +59.3%. Below-average margins reflect competitive or cost pressures. Return on Equity is -83.2%.
Is BHST growing earnings?
Yes, BHST earnings are accelerating — EPS growth of +25.0% exceeds the 5-year CAGR of N/A. TTM net income reached $-11M. Earnings momentum is strengthening.
What was BHST's best earnings year?
BioHarvest Sciences Inc. Common Stock's highest annual net income on record is $0.00, achieved in fiscal year 2013. Earnings history on this page spans 2013 to 2025 and includes all annual and quarterly figures.
What were BHST's earnings last quarter?
BHST's most recent reported quarter was Q1 2026. Net income was $-3M with diluted EPS of $-0.12. For a full breakdown of all quarters, see the quarterly earnings table on this page.